Clinical Trial

Comparison of the Efficacy of Extracorporeal Shock Wave Therapy and Suprascapular Nerve Block in Hemiplegic Shoulder Pain

Study acronym: ESWT-HSP
Completed
View on ClinicalTrials.gov →
Summary
This study aimed to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and suprascapular nerve block (SSNB) with conventional treatment for hemiplegic shoulder pain. A total of 67 patients aged 45-70 years, treated at the Department of Physical Therapy and Rehabilitation at Başakşehir Çam and Sakura City Hospital between April 1, 2023, and January 1, 2024, were randomly assigned to three groups. The first group (n=24) received conventional treatment, the second group (n=22) received conventional treatment plus one session of ultrasound-guided suprascapular nerve block, and the third group (n=21) received conventional treatment plus ESWT applied for 2 weeks, 4 days per week at 12 Hz and 2-3 bars. All groups were evaluated clinically and ultrasonographically before treatment, at 1 month, and at 3 months. Pain intensity was assessed using the visual analog scale, upper extremity motor function with the Fugl-Meyer Motor Scale, and supraspinatus muscle tear size via ultrasound.
Trial Details
NCT Number NCT07485192
Lead Sponsor Kars State Hospital
Conditions Hemiplegic Shoulder Pain
Enrollment 67 participants
Start Date 2023-04-01
Primary Completion 2024-01-01 (estimated)
Study Completion 2024-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20